PDF
ePub
Citation
Print
Abstract
Background
Leptin is a hormone which is produced in adipose tissue and regulates food intake and body weight. Leptin is known to correlate with body adiposity such as body mass index. Blood leptin concentration is not different between non-diabetics and diabetics. And It affect not only food intake but may be one of the key factors in the developement of insulin resistance. Recent studies suggest a complex relationship between leptin and insulin resistance or insulin. Therefore we examined the relationship between leptin and anthropometric, biochemical parameters, and insulin resistance in type 2 diabetics.
Method
The study subjects were 144 patients with type 2 diabetes who visited Kyungpook national university hospital. Anthropometric parameters such as body fat mass, soft lean mass, BMI, arm circumference, skin fold thickness of several sites were measured. Percent body fat were calculated from Brozek fomula, body density were calculated from Jackson and Pollock fomula. Fasting blood leptin and metabolic varables such as C-peptide, HbA1C, insulin, HDL, LDL, TG, total cholesterol, FFA, HOMA-IR were measured. The relationships of blood leptin concentration with clinical data were analyzed with SPSS program.
Result
Blood leptin concentrations were 8.2 ± 5.39 ng/mL in women with type 2 diabetes and 5.1 ± 5.55 ng/mL in men with type 2 diabetes (P-value: 0.01). Percent body fat, FFA were higher in women than men but arm circumference, soft lean mass, waist circumference were higher in men than women (P-value < 0.05). Leptin concentration correlated with BMI, percent body fat, insulin, TG, body fat mass, waist circumference, HOMA-IR. And insulin, C-peptide, total cholesterol, TG were also correlated with leptin only in women with type 2 diabetes. Waist circumference and percent body fat were independent variables which influence blood leptin concentration in multiple regression analysis.
Conclusion
Blood leptin concentrations are related to parameters such as percent body fat, waist circumference, BMI, body fat mass, insulin, TG, HOMA-IR in type 2 diabetics. The relationship between leptin and obesity or HOMA-IR suggests that leptin may be a one of factors in developement of insulin resistance.
Figures and Tables
Table 3
Relationship of Serum Leptin and Clinical Data in the Patients with Type 2 Diabetes Mellitus
References
1. Zang Y, Proenca R, Maffei M, Barone M, Leopold L, Friedman JM. Positional cloning of the mouse ob gene and its human homologue. Nature. 1994. 37:425–432.
2. Campfield L, Smith M, Guisez Y, Devos R, Burn P. Recombinant mouse OB protein: evidence for a peripheral signal linking adiposity and central neural networks. Science. 1995. 269:546–548.
3. Pellymounter M, Cullen M, Baker M. Effects of the obese gene product on body weight regulation in ob/ob mice. Science. 1995. 269:540–543.
4. Bray GA, York DA. Leptin and clinical medicine: a new piece in the puzzle of obesity. J Clin Endocrinol Metab. 1997. 82:2771–2776.
5. Considine RV, Caro JF. Leptin: genes, concepts and clinical perspective. Horm Res. 1996. 46:249–256.
6. Tuominen JA, Ebeling P, Stenman UH, Stephens TW, Koivisto VA. Leptin synthesis is resistant to acute effects of insulin in IDDM patients. J Clin Endocrinol Metab. 1997. 82:381–382.
7. Segal K, Landt M, Klein S. Relationship between insulin sensitivity and plasma leptin concentration in lean and obese men. Diabetes. 1996. 45:987–991.
8. Coleman DL. Obese and diabetes: two mutant genes causing diabetes-obesity syndromes in mice. Diabetologia. 1978. 14:141–148.
9. Pollock ML, Laughridge EE, Coleman B, Linnerud AC, Jackson A. Prediction of body density in young and middle-aged women. J Appl Physiol. 1975. 38:745–749.
10. Jackson AS, Pollock ML. Generalized equations for predicting body density of men. Br J Nutr Jan. 2004. 91:161–168.
11. Kim HK, Matsuura Y, Tanaka K, Inagaki A, Nakadomo F. The equation relating body density to percent body fat in boys and girls. Ann Physiol Anthropol. 1993. 12:71–77.
12. Considine RV, Sinha MK, Heiman ML, McKee LJ, Bauer TL, Caro JF. Serum leptin concentrations in normal weight and obese humans. N Eng J Med. 1996. 334:292–295.
15. Widjaja A, Stratton IM, Horn R, Holman RR, Turner R, Brabant G. UKPDS 20: plasma leptin, obesity, and plasma insulin in type 2 diabetic subjects. J Clin Endocrinol Metab. 1997. 82:654–657.
18. Comizio R, Pietrobelli A, Tan YX, Wang Z, Withers RT, Heymsfield SB, Boozer CN. Total body lipid and triglyceride response to energy deficit: relevance to body composition models. Am Physiol. 1998. 274(5 Pt 1):E860–E866.
19. Stumvoll M, Goldstein BJ, van Haeften TW. Type 2 diabetes: principles of pathogenesis and therapy. Lancet. 2005. 365:1333–1346.
20. Schrauwen P, Hesselink MK. Oxidative capacity, lipotoxicity, and mitochondrial damage in type 2 diabetes. Diabetes. 2004. 53:1412–1417.
21. Kennedy A, Getts TW, Watson P, Wallace P, Ganaway E, Pan Q, Garvey WT. The metabolic significance of leptin in humans: Gender-based differences in relationship to adiposity, insulin sensitivity, and energy expenditure. J Cli Endocrinol Metab. 1997. 82:1293–1300.
22. Tufano A, Marzo P, Enrini R, Morricone L, Caviezel F, Ambrosi B. Anthropometric, hormonal and biochemical differences in lean and obese women before and after menopause. Endocrinol Invest. 2004. 27:648–653.
23. Huang KC, Lin RC, Kormas N, Lee LT, Chen CY, Gill TP, Caterson ID. Plasma leptin is associated with insulin resistance independent of age, body mass index, fat mass, lipids, and pubertal development in nondiabetic adolescents. Int J Obes Relat Metab Disord. 2004. 28:470–475.
24. Hodge AM, Boyko EJ, de Courten M, Zimmet PZ, Chitson P, Tuomilehto J, Alberti KG. Leptin and other components of the Metabolic Syndrome in Mauritius-a factor analysis. Int J Obes Relat Metab Disord. 2001. 25:126–131.
25. Soderberg S, Ahren B, Eliasson M, Dinesen B, Olsson T. The association between leptin and proinsulin is lost with central obesity. J Intern Med. 2002. 252:140–148.
XML Download